Note: United Biologics's revenues are gauged from an analysis of company filings.
United Biologics's Income Statement (based on Industry Averages)
United Biologics P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Investor Activity
United Biologics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
April 29, 2013
17
100%
$5 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that United Biologics is developing and marketing.
United Biologics doesn't have any recent trademark applications, indicating United Biologics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
ALLERGY ALLAY DROPS Custom manufacture of pharmaceutical preparations for allergy relief
06/26/2019
MYALLERGYPAL Computer application software for mobile devices, namely, software for patients to access information related to and maintain compliance with allergy treatment
09/04/2013
UNITED ALLERGY SERVICES medical testing services, namely, allergy testing and analysis
02/15/2012
See all trademarks and details in the Full Report.
Market Share of United Biologics's Largest Competitors
A competitive analysis shows these companies are in the same general field as United Biologics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to United Biologics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
Future Competition: United Biologics's Fastest Growing Competitors
These companies are in the same general field as United Biologics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.